Objectives Lymphopenic (<724 lymphocytes/µL) community-acquired pneumonia (L-CAP)
is an immunophenotype with an increased risk of mortality. We aimed to characterize the l-…

Rationale: Assessment of the inflammatory response can help the decision-making process
when diagnosing community-acquired pneumonia (CAP), but there is a lack of information …

Background Bronchiectasis (BE) is a chronic structural lung disease with frequent exacerbations,
some of which require hospital admission though no clear associated factors have …

Background and objective The objective of this study was to evaluate the effect of age and
comorbidities, smoking and alcohol use on microorganisms in patients with community‐…

Pneumonia causes a significant burden of disease worldwide. Although all populations are
at risk of pneumonia, those at extremes of age and those with immunosuppressive disorders, …

Bronchiectasis is a chronic structural disease associated with exacerbations that provoke
systemic inflammation. We aimed to evaluate the systemic acute proinflammatory cytokine and …

Community-acquired pneumonia (CAP) is a serious infection that may occasionally rapidly
evolve provoking organ dysfunctions. We aimed to characterize CAP presenting with organ …

Background Non-cystic fibrosis bronchiectasis is a chronic structural lung condition that
courses with recurrent infectious exacerbations that lead to frequent antibiotic treatment making …

COVID-19 has been a diagnostic and therapeutic challenge. It has marked a paradigm shift
when considering other types of pneumonia etiology. We analyzed the biomarkers related to …

Background: Platelets have been shown to have a thrombotic and immune role in infections.
However, its potential activation in community-acquired pneumonia (CAP) remains poorly …